Prevalence of Parkinson Disease in Hospitalized Patients With Congestive Heart Failure
暂无分享,去创建一个
N. M. Enwerem | Priscilla O. Okunji | Julius S. Ngwa | S. G. Karavatas | Thomas V. Fungwe | Thomas O. Obisesan | T. Obisesan | J. Ngwa | T. Fungwe | S. Karavatas | N. Enwerem
[1] A. Kaplin,et al. HOW COMMON ARE THE “COMMON” NEUROLOGIC DISORDERS? , 2007, Neurology.
[2] M. Kamal,et al. An overview on the correlation of neurological disorders with cardiovascular disease , 2014, Saudi journal of biological sciences.
[3] R. Hauser,et al. Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey. , 2004, Parkinsonism & related disorders.
[4] K. Nagata,et al. High Prevalence of Gastroesophageal Reflux Disease in Parkinson's Disease: A Questionnaire-Based Study , 2013, Parkinson's disease.
[5] D. Maraganore,et al. Comorbid conditions associated with Parkinson's disease: A population‐based study , 2006, Movement disorders : official journal of the Movement Disorder Society.
[6] C. C. Johnson,et al. Parkinson's disease and its comorbid disorders , 1994, Neurology.
[7] R. Hamill,et al. Parkinson's disease. , 2012, Sub-cellular biochemistry.
[8] D. Weintraub,et al. Depression in veterans with Parkinson's disease: frequency, co‐morbidity, and healthcare utilization , 2007, International journal of geriatric psychiatry.
[9] Chung-Yi Li,et al. Risk of Parkinson Disease Onset in Patients With Diabetes , 2012, Diabetes Care.
[10] Tie-mei Zhang,et al. Nonmotor symptoms in patients with Parkinson disease , 2016, Medicine.
[11] M. Tagliati,et al. Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease. , 2015, Parkinsonism & related disorders.
[12] M. Ziman,et al. A Systematic Review and Meta-Analysis of Strength Training in Individuals With Multiple Sclerosis Or Parkinson Disease , 2015, Medicine.
[13] G Hu,et al. Body mass index and the risk of Parkinson disease , 2006, Neurology.
[14] Bradley A. Evanoff,et al. Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries , 2010, Neuroepidemiology.
[15] E. Wolters,et al. Management of non-motor symptoms in advanced Parkinson disease , 2008, Journal of the Neurological Sciences.
[16] Xuemei Huang,et al. Diabetes and Risk of Parkinson’s Disease , 2011, Diabetes Care.
[17] M. Nance. Therapy in Huntington’s Disease: Where Are We? , 2012, Current Neurology and Neuroscience Reports.
[18] R. Barker,et al. Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[19] Gerhard Ransmayr,et al. Cognitive impairment in Parkinson's disease. , 2015, Psychiatria Danubina.
[20] H. Fukuyama,et al. Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan , 2010, Journal of the Neurological Sciences.
[21] H. Reichmann,et al. Parkinson’s disease between internal medicine and neurology , 2015, Journal of Neural Transmission.
[22] C. Tanner,et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.
[23] D. Huse,et al. Burden of illness in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[24] V. Roger. Epidemiology of Heart Failure , 2013, Circulation research.